Market Closed -
Other stock markets
|
Pre-market 07:01:53 am | |||
64.92 USD | -0.82% | 65.48 | +0.87% |
May. 07 | Ligand Pharmaceuticals Investing in Agenus to Fund Development of Oncology Drug Candidates | MT |
May. 02 | UBS Adjusts Price Target on Gilead Sciences to $70 From $75, Maintains Neutral Rating | MT |
- Stock Market
- Equities
- GILD Stock
- News Gilead Sciences, Inc.